Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer

NCT05014815 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)
Nonsmall Cell Lung Cancer, Stage IIIB
Nonsmall Cell Lung Cancer, Stage IV

Interventions

DRUG: Ociperlimab
DRUG: Tislelizumab
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Nab paclitaxel
DRUG: Cisplatin
DRUG: Pemetrexed
DRUG: Placebo

Sponsor

BeiGene